Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Announces Closing of First Tranche of Private Placement and Shares for Debt

Marketwired June 23, 2014

Ventripoint to Exhibit at the 25th Annual Scientific Sessions of the American Society of Echocardiography

Marketwired June 20, 2014

Ventripoint Extends its Near-Term Secured Debenture

Marketwired May 30, 2014

Ventripoint Enters Into Engagement Letter for Private Placement of Units

Marketwired May 22, 2014

Montefiore Hospital in New York City to Conduct Cardiac Re-Admission Study Using the Ventripoint VMS(TM) Heart Analysis System

Marketwired April 15, 2014

Montefiore Hospital in New York City to Conduct Cardiac Re-Admission Study Using the Ventripoint VMS(TM) Heart Analysis System

Marketwired April 15, 2014

Ventripoint Corporate Update and Resignation of Director

Marketwired April 8, 2014

Ventripoint Corporate Update and Resignation of Director

Marketwired April 8, 2014

Ventripoint VMS(TM) Heart Analysis System Used to Monitor Therapy in Pulmonary Hypertension and Valve Replacement in Congenital Heart Disease

Marketwired April 2, 2014

Ventripoint VMS(TM) Heart Analysis System Used to Monitor Therapy in Pulmonary Hypertension and Valve Replacement in Congenital Heart Disease

Marketwired April 2, 2014

Ventripoint Diagnostics (V.VPT), up 20%, VMS(TM) heart analysis system clears US FDA hurdle

Gaalen Engen March 10, 2014

IIROC Trade Resumption - VentriPoint Diagnostics Ltd.

Newsfile March 10, 2014

IIROC Trading Resumption - VPT

Canada NewsWire March 10, 2014

FDA Clears Ventripoint VMS(TM) Heart Analysis System for Use in Patients with Pulmonary Arterial Hypertension

Marketwired March 10, 2014

IIROC Trading Halt - VPT

Canada NewsWire March 7, 2014

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile March 7, 2014

Ventripoint Announces 510(k) Submission for VMS Heart Analysis System and Issuance of Shares for Debt

Marketwired January 23, 2014

Ventripoint Diagnostics (V.VPT) re-tools for 510(k) re-submit – shares recover 83%

Gaalen Engen December 15, 2013

Ventripoint Announces Regulatory Update for VMS(tm) Heart Analysis System

TheNewsWire December 13, 2013

Ventripoint Announces Planned Response to FDA Notification and Expanded Sales Efforts Outside of the United States

TheNewsWire November 25, 2013